Home
About
Leadership
Technology
Pipeline
News
Careers
Contact

Recent Posts

Artiva Biotherapeutics Strengthens Leadership Team with the Appointment of Christopher Horan as Chief Technical Operations Officer
Artiva Biotherapeutics to Present Preclinical Data for AB-201, a HER2-Targeting CAR-NK Cell Therapy, at SITC 36th Annual Meeting
Artiva Biotherapeutics Demonstrates Its Commitment to Corporate Social Responsibility by Joining Pledge 1% Movement
Artiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply
Artiva Biotherapeutics Appoints Two New Independent Members to Its Board of Directors

Archives

January 2022
October 2021
September 2021
August 2021
May 2021
April 2021
February 2021
January 2021
December 2020
November 2020
June 2020

Categories

Press Releases

Archives

January 2022
October 2021
September 2021
August 2021
May 2021
April 2021
February 2021
January 2021
December 2020
November 2020
June 2020

Category: Executives

Fred Aslan, M.D.

Jennifer Bush

Michael Faerm

Peter Flynn, Ph.D.

Christopher Horan

Jason Litten, M.D.

Eugene Helsel

John Lim, Pharm.D.

Steve Potter

Heather Raymon, Ph.D.

Privacy Policy
Terms

© Artiva Biotherapeutics, Inc., 2022

Sign up for news updates

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy